VolitionRx Limited
VNRX
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.19
FAIR PRICE
$0.16
MARGIN
$0.03
P/E Ratio
N/A
Div. Yield
N/A
ROE
76.8%
Exceptional
Market Cap
$20M
Small-cap
COMING SOON
Get notified when VNRX's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Cameron Reynolds
COUNTRY
US
HEADQUARTERS
Henderson
SECTOR
Healthcare
EXCHANGE
AMEX
METHODOLOGY
How we calculate VNRX's fair price
VolitionRx Limited's fair price of $0.16 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.19, VNRX trades 15.0% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting VNRX's risk profile.
RELATIVE · 30%
Comparing VNRX's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for VNRX, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate VNRX's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for VNRX.
Explore on BuliosFAQ
What is the fair price of VNRX?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for VolitionRx Limited is $0.16. At the current market price of $0.19, VNRX trades 15.0% above its calculated fair value.
Is VNRX overvalued or undervalued?+
VolitionRx Limited is currently overvalued based on our valuation model. The stock trades at $0.19, which is 15.0% above the fair price of $0.16.
How often is VNRX's fair price updated?+
We update fair price calculations for VNRX daily after market close. The current fair price of $0.16 incorporates the latest market data and sector multiples.
What factors affect VNRX's fair price calculation?+
VNRX's fair price of $0.16 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 76.8%.
Is VNRX a good buy right now?+
At $0.19, VNRX trades 15.0% above our fair value estimate of $0.16. The stock is currently overvalued. ROE stands at 76.8% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does VNRX pay dividends?+
VNRX does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.